Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOROX CO /DE/CLX · Entity 3474 | EVP - Chief Growth Officer | October 05, 2021 | November 03, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOROX CO /DE/
Report date October 05, 2021 · Filed November 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,954 |
Reported balance
After 2021-10-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-10-05 · Tax withholding · Disposed 59 · Balance 9,954 F1: Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock. |
| Common StockSEC Table I · non-derivative | Direct | 9,371 |
Reported balance
After 2021-10-05 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2021-10-05 · Tax withholding · Disposed 583 · Balance 9,371 F1: Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock. F2: Includes 53 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock.
F2: Includes 53 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2021 Filed Nov 3, 2021 20:26 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 583 | $162.62 | $94,807.46 |
DisclosureSEC source: 0001225208-21-013527 · doc4.xml · nonDerivative · entry 2 Matta Tony · CIK 0001827104 · EVP - Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,371 F1 · kind: Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock. F2 · balance_after: Includes 53 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| October 05, 2021 Filed Nov 3, 2021 20:26 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 59 | $162.62 | $9,594.58 |
DisclosureSEC source: 0001225208-21-013527 · doc4.xml · nonDerivative · entry 1 Matta Tony · CIK 0001827104 · EVP - Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,954 F1 · kind: Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock. Read SEC document |
| September 21, 2021 Filed Sep 23, 2021 23:14 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 13,469 | $0.00 Strike: $163.77 | $0.00 |
DisclosureSEC source: 0001225208-21-012517 · doc4.xml · derivative · entry 2 Matta Tony · CIK 0001827104 · EVP - Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,469 Underlying: Common Stock · 13,469 shares Expires 2031-09-21 F2 · kind: Option vests in 4 equal installments on each of October 5 of 2022, 2023, 2024 and 2025. F2 · derivative.exercise_date: Option vests in 4 equal installments on each of October 5 of 2022, 2023, 2024 and 2025. Read SEC document |
| September 21, 2021 Filed Sep 23, 2021 23:14 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 1,831 | $163.77 | $299,862.87 |
DisclosureSEC source: 0001225208-21-012517 · doc4.xml · nonDerivative · entry 1 Matta Tony · CIK 0001827104 · EVP - Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,960 F1 · kind: The Restricted Stock Units will vest in 4 equal installments on each of October 5 of 2022, 2023, 2024 and 2025. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 20:46 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 6,072 | $0.00 Strike: $209.11 | $0.00 |
DisclosureSEC source: 0001225208-20-012311 · doc4.xml · derivative · entry 3 Matta Tony · CIK 0001827104 · EVP - Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,072 Underlying: Common Stock · 6,072 shares Expires 2030-10-05 F3 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F3 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 20:46 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 956 | $209.11 | $199,909.16 |
DisclosureSEC source: 0001225208-20-012311 · doc4.xml · nonDerivative · entry 2 Matta Tony · CIK 0001827104 · EVP - Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,129 F2 · kind: The Restricted Stock Units will vest in 4 installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 20:46 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 7,173 | $209.11 | $1,499,946.03 |
DisclosureSEC source: 0001225208-20-012311 · doc4.xml · nonDerivative · entry 1 Matta Tony · CIK 0001827104 · EVP - Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,173 F1 · kind: The Restricted Stock Units will vest in 3 installments - 1/3 on each of the first, second and third anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.